Cargando…
Evaluation of Performance of the BD Veritor SARS-CoV-2 Chromatographic Immunoassay Test in Patients with Symptoms of COVID-19
Autores principales: | Kilic, Abdullah, Hiestand, Brian, Palavecino, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091854/ https://www.ncbi.nlm.nih.gov/pubmed/33637583 http://dx.doi.org/10.1128/JCM.00260-21 |
Ejemplares similares
-
Performance of the BD Veritor system SARS-CoV-2 antigen test among asymptomatic collegiate athletes: A diagnostic accuracy study
por: Kepczynski, Casey M., et al.
Publicado: (2021) -
Comparison of the SARS-CoV-2 BD Veritor Nasal Antigen Test with Nasopharyngeal Reverse Transcription-PCR in Symptomatic Patients
por: Koga, Paula, et al.
Publicado: (2022) -
Clinical Evaluation of BD Veritor SARS-CoV-2 and Flu A+B Assay for Point-Of-Care System
por: Christensen, Katherine, et al.
Publicado: (2022) -
Clinical Evaluation of BD Veritor SARS-CoV-2 Point-of-Care Test Performance Compared to PCR-Based Testing and versus the Sofia 2 SARS Antigen Point-of-Care Test
por: Young, Stephen, et al.
Publicado: (2020) -
Analytical performance of the BD veritor™ system for rapid detection of influenza virus A and B in a primary healthcare setting
por: Mese, Sevim, et al.
Publicado: (2016)